Cargando…
Role of Fcγ receptors in HER2-targeted breast cancer therapy
Several therapeutic monoclonal antibodies (mAbs), including those targeting epidermal growth factor receptor, human epidermal growth factor receptor 2 (HER2), and CD20, mediate fragment crystallizable gamma receptor (FcγR)–dependent activities as part of their mechanism of action. These activities i...
Autores principales: | Musolino, Antonino, Gradishar, William J, Rugo, Hope S, Nordstrom, Jeffrey L, Rock, Edwin P, Arnaldez, Fernanda, Pegram, Mark D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739678/ https://www.ncbi.nlm.nih.gov/pubmed/34992090 http://dx.doi.org/10.1136/jitc-2021-003171 |
Ejemplares similares
-
Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties
por: Nordstrom, Jeffrey L, et al.
Publicado: (2011) -
Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer
por: Pegram, Mark, et al.
Publicado: (2023) -
Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions
por: Qureshi, O. S., et al.
Publicado: (2017) -
Fcγ receptor targeting in RA
por: Takai, Toshiyuki, et al.
Publicado: (2012) -
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated
ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial
por: Rugo, Hope S., et al.
Publicado: (2021)